SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vimal Pandey, Maleppillil Vavachan Vijayakumar, Amrendra Kumar Ajay, Parmanand Malvi, Manoj Kumar Bhat, Diet-induced obesity increases melanoma progression: Involvement of Cav-1 and FASN, International Journal of Cancer, 2012, 130, 3
  2. 2
    Ming-Wei Lin, An-Shen Lin, Deng-Chyang Wu, Sophie S.W. Wang, Fang-Rong Chang, Yang-Chang Wu, Yaw-Bin Huang, Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis, Food and Chemical Toxicology, 2012,

    CrossRef

  3. 3
    H-W Chen, Y-F Chang, H-Y Chuang, W-T Tai, J-J Hwang, Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model, Prostate Cancer and Prostatic Diseases, 2012,

    CrossRef

  4. 4
    Nan Li, Xiaodong Bu, Peng Wu, Pingping Wu, Peilin Huang, The “HER2–PI3K/Akt–FASN Axis” Regulated Malignant Phenotype of Colorectal Cancer Cells, Lipids, 2012, 47, 4, 403

    CrossRef

  5. 5
    Cheng-Yu Ko, Lanxiao Wu, Ashwin M. Nair, Yi-Ting Tsai, Victor K. Lin, Liping Tang, The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis, Biomaterials, 2012, 33, 3, 876

    CrossRef

  6. 6
    Hui-Yen Chuang, Ya-Fang Chang, Jeng-Jong Hwang, Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal, Biomedicine & Pharmacotherapy, 2011, 65, 4, 286

    CrossRef

  7. You have free access to this content7
    Peng-Yu Yang, Kai Liu, Chongjing Zhang, Grace Y. J. Chen, Yuan Shen, Mun Hong Ngai, Martin J. Lear, Shao Q. Yao, Chemical Modification and Organelle-Specific Localization of Orlistat-Like Natural-Product-Based Probes, Chemistry – An Asian Journal, 2011, 6, 10
  8. 8
    BAB de Andrade, JE León, R Carlos, W Delgado-Azañero, A Mosqueda-Taylor, E Graner, OP de Almeida, Expression of fatty acid synthase (FASN) in oral nevi and melanoma, Oral Diseases, 2011, 17, 8
  9. 9
    S. Navina, C. Acharya, J. P. DeLany, L. S. Orlichenko, C. J. Baty, S. S. Shiva, C. Durgampudi, J. M. Karlsson, K. Lee, K. T. Bae, A. Furlan, J. Behari, S. Liu, T. McHale, L. Nichols, G. I. Papachristou, D. Yadav, V. P. Singh, Lipotoxicity Causes Multisystem Organ Failure and Exacerbates Acute Pancreatitis in Obesity, Science Translational Medicine, 2011, 3, 107, 107ra110

    CrossRef

  10. You have free access to this content10
    Richard Flavin, Giorgia Zadra, Massimo Loda, Metabolic alterations and targeted therapies in prostate cancer, The Journal of Pathology, 2011, 223, 2
  11. 11
    Simone Fulda, Guido Kroemer, Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease, Antioxidants & Redox Signaling, 2011, 15, 12, 2937

    CrossRef

  12. 12
    Karina G. Zecchin, Luciane C. Alberici, Maria Francesca Riccio, Marcos N. Eberlin, Aníbal E. Vercesi, Edgard Graner, Rodrigo R. Catharino, Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells, Rapid Communications in Mass Spectrometry, 2011, 25, 3
  13. 13
    Wen-Hua Zhao, Li-Fang Gao, Wen Gao, Yong-Sheng Yuan, Chun-Chun Gao, Li-Ge Cao, Zi-Zheng Hu, Jian-Qiang Guo, Ying-Xia Zhang, Weight-reducing effect ofAcer truncatumBunge may be related to the inhibition of fatty acid synthase, Natural Product Research, 2011, 25, 4, 422

    CrossRef

  14. 14
    Ali Tiss, Hans Lengsfeld, Robert Verger, A comparative kinetic study on human pancreatic and Thermomyces lanuginosa lipases: Inhibitory effects of tetrahydrolipstatin in the presence of lipid substrates, Journal of Molecular Catalysis B: Enzymatic, 2010, 62, 1, 19

    CrossRef

  15. 15
    Peng-Yu Yang, Kai Liu, Mun Hong Ngai, Martin J. Lear, Markus R. Wenk, Shao Q. Yao, Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities, Journal of the American Chemical Society, 2010, 132, 2, 656

    CrossRef

  16. 16
    Mun H. Ngai, Peng-Yu Yang, Kai Liu, Yuan Shen, Markus R. Wenk, Shao Q. Yao, Martin J. Lear, Click-based synthesis and proteomic profiling of lipstatin analogues, Chemical Communications, 2010, 46, 44, 8335

    CrossRef

  17. 17
    Richard Flavin, Stephane Peluso, Paul L Nguyen, Massimo Loda, Fatty acid synthase as a potential therapeutic target in cancer, Future Oncology, 2010, 6, 4, 551

    CrossRef

  18. 18
    Javier A. Menendez, Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010, 1801, 3, 381

    CrossRef

  19. 19
    Karina G Zecchin, Franco A Rossato, Helena F Raposo, Daniela R Melo, Luciane C Alberici, Helena CF Oliveira, Roger F Castilho, Ricardo D Coletta, Aníbal E Vercesi, Edgard Graner, Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis, Laboratory Investigation, 2010, 91, 2, 232

    CrossRef

  20. 20
    Simone Fulda, Lorenzo Galluzzi, Guido Kroemer, Targeting mitochondria for cancer therapy, Nature Reviews Drug Discovery, 2010, 9, 6, 447

    CrossRef

  21. 21
    T. Migita, S. Ruiz, A. Fornari, M. Fiorentino, C. Priolo, G. Zadra, F. Inazuka, C. Grisanzio, E. Palescandolo, E. Shin, C. Fiore, W. Xie, A. L. Kung, P. G. Febbo, A. Subramanian, L. Mucci, J. Ma, S. Signoretti, M. Stampfer, W. C. Hahn, S. Finn, M. Loda, Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer, JNCI Journal of the National Cancer Institute, 2009, 101, 7, 519

    CrossRef